Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prioritising neonatal medicines research: UK Medicines for Children Research Network scoping survey ; volume:9 ; number:1 ; day:12 ; month:8 ; year:2009 ; pages:1-5 ; date:12.2009
BMC pediatrics ; 9, Heft 1 (12.8.2009), 1-5, 12.2009
- Creator
-
Turner, Mark A.
- Contributor
-
Lewis, Sara
Hawcutt, Daniel B.
Field, D.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2431-9-50
- URN
-
urn:nbn:de:1111-2016081311203
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Turner, Mark A.
- Lewis, Sara
- Hawcutt, Daniel B.
- Field, D.
- SpringerLink (Online service)
Other Objects (12)
The FIMP Medicines for Children Research Network
Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Network medicines™
A research agenda to promote affordable and quality assured medicines
Traditional medicines as a mechanism for driving research innovation in Africa
Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity
Ocular medicines in children: the regulatory situation related to clinical research
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Translational medicines “Ecosystem”
Evidence-based quality criteria in research, development and application of Chinese medicines
Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency)
Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment
The FIMP Medicines for Children Research Network
Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Network medicines™
A research agenda to promote affordable and quality assured medicines
Traditional medicines as a mechanism for driving research innovation in Africa
Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity
Ocular medicines in children: the regulatory situation related to clinical research
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Translational medicines “Ecosystem”
Evidence-based quality criteria in research, development and application of Chinese medicines
Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency)
Regulations Governing Medicines for Maternal and Neonatal Health: A Landscape Assessment
The FIMP Medicines for Children Research Network
Successful private–public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines
Network medicines™
A research agenda to promote affordable and quality assured medicines
Traditional medicines as a mechanism for driving research innovation in Africa
Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity
Ocular medicines in children: the regulatory situation related to clinical research
Review: UK medicines likely to be affected by the proposed European Medicines Agency’s guidelines on phthalates
Translational medicines “Ecosystem”
Evidence-based quality criteria in research, development and application of Chinese medicines
Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency)